Cycle view
- Bloc
- Organisation
- Théorie
- Pratique
- Autres
- Crédits
Information
Professor R. HUSTINX
Nuclear Medicine Service
B35 - CHU - 4000 Liege
Phone: 04/366.71.99 - Fax: 04/366.82.57
e-mail address : rhustinx@chuliege.be
Nuclear Medicine Service
B35 - CHU - 4000 Liege
Phone: 04/366.71.99 - Fax: 04/366.82.57
e-mail address : rhustinx@chuliege.be
The first two years of the specialised master in nuclear medicine corresponds to the programme of the first two years of the specialised master in internal medicine. Applicants must comply each year with the conditions for this specialised Masters in terms of both the classes taken and the assessments.
Collegiality
Coordinator : Roland HUSTINX
Claire BERNARD, Etienne CAVALIER, Philippe COUCKE, Anne-Françoise DONNEAU, Laurent DREESEN, Chantal HUMBLET, Sébastien JODOGNE, Philippe MARTINIVE, Paul MEUNIER, Véra PIRLET, Mallory SALVE, Alain SERET, David STRIVAY, Nadia WITHOFS.
Claire BERNARD, Etienne CAVALIER, Philippe COUCKE, Anne-Françoise DONNEAU, Laurent DREESEN, Chantal HUMBLET, Sébastien JODOGNE, Philippe MARTINIVE, Paul MEUNIER, Véra PIRLET, Mallory SALVE, Alain SERET, David STRIVAY, Nadia WITHOFS.
| Code | Détails | Bloc | Organisation | Théorie | Pratique | Autres | Crédits |
|---|---|---|---|---|---|---|---|
| MEDI2012-1 | Inter-university and university theory courses, including seminars - [80h Seminar]
Collégialité
| B1 | TA | 71 | - | [+] | 15 |
| MSTG2039-1 | Placements, including supervised exercices - [11half-d internship]
Collégialité
| B1 | - | 250 | [+] | 45 | |
| MEDI2012-2 | Inter-university and university theory courses, including seminars - [80h Seminar]
Collégialité
| B2 | TA | 71 | - | [+] | 15 |
| MSTG2039-2 | Placements, including supervised exercices - [11half-d internship]
Collégialité
| B2 | - | 250 | [+] | 45 | |
| MEDI2000-3 | Inter-university theoretical courses, 3rd year
Collégialité
| B3 | TA | 24 | - | - | 6 |
| PHYS2009-2 | Modern physics | B3 | Q1 | 2 | |||
| Part A | 20 | - | - | ||||
| Part D | - | 15 | - | ||||
| MCMN2001-1 | Radiopharmacy and radiochemistry, 3rd year | B3 | 25 | 50 | - | 2 | |
| MCMN2009-1 | Cellular and human radiobiology | B3 | TA | 4 | |||
| Radiobiologie cellulaire et humaine : histopathologie, 3rd year | 18 | 5 | - | ||||
| Radiobiologie cellulaire et humaine : biochimie, 3rd year | 30 | - | - | ||||
| MCMN2005-1 | Radioprotection | B3 | TA | 6 | |||
| Problèmes d'hygiène, 3rd year | 15 | - | - | ||||
| Techniques de radioprotection et compléments, 3rd year | 15 | 10 | - | ||||
| Techniques de radioprotection et législation, 3rd year | 5 | - | - | ||||
| MCMN2006-1 | Using radioactive indicators and measuring techniques, 3rd year | B3 | TA | 15 | 30 | - | 2 |
| RADI2004-4 | Elements of Medical IT, 3rd year | B3 | 15 | - | - | 2 | |
| MCMN2008-1 | Elements of medical imaging | B3 | 30 | - | - | 2 | |
| MCMN2007-1 | Interdisciplinary seminars on oncological therapy | B3 | 45 | - | - | 2 | |
| STAT0420-1 | Biostatistics 2 | B3 | Q1 | 15 | 15 | - | 2 |
| MSTG2025-1 | Placements, 3rd year - [11half-d internship]
Collégialité
| B3 | TA | - | - | [+] | 30 |
| MEDI2000-4 | Inter-university theoretical courses, 4th year
Collégialité
| B4 | TA | 24 | - | - | 15 |
| MEDI2010-3 | University theory courses | B4 | TA | 10 | |||
| Techniques in vivo : diagnostics, thérapeutiques, 4th year | 40 | 40 | - | ||||
| Techniques in vitro, 4th year | 30 | 30 | - | ||||
| MEDI2011-1 | Seminars, 4th year - [50h Seminar]
Collégialité
| B4 | TA | - | - | [+] | 5 |
| MSTG2025-2 | Placements, 4th year - [11half-d internship]
Collégialité
| B4 | TA | - | - | [+] | 30 |
| MEDI2000-5 | Inter-university theoretical courses
Collégialité
| B5 | TA | 24 | - | - | 15 |
| MEDI2010-4 | University theory courses | B5 | TA | 10 | |||
| Techniques in vivo : diagnostics, thérapeutiques, 5th year | 40 | 40 | - | ||||
| Techniques in vitro, 5th year | 30 | 30 | - | ||||
| MEDI2011-2 | Seminars, 5th year - [50h Seminar]
Collégialité
| B5 | TA | - | - | [+] | 5 |
| MTFE2024-1 | Training including final work - [11half-d internship]
Collégialité
| B5 | TA | - | - | [+] | 30 |